IBM, Chartered, Samsung and ARM to Develop 32nm and 28nm Systems-on-a-Chip

IBM, Chartered Semiconductor Manufacturing Ltd., Samsung Electronics, Co., Ltd., and ARM today announced they will develop a comprehensive 32 nanometer (nm) and 28nm Systems-on-a-Chip (SoCs) design platform based on high-k metal-gate (HKMG) technology from the IBM-led joint-development alliance.

Under this multi-year collaboration, ARM will develop and license a design platform of physical intellectual property (IP) including logic, memory and interface products for the Common Platform technology alliance of IBM, Chartered and Samsung for distribution to their customers.

ARM also announced its intent to develop customized physical IP targeted at achieving optimal power, performance, and area for their current and future Cortex™ processor family leveraging the unique attributes of the Common Platform HKMG 32nm/28nm technology. The HKMG technology breaks down the historical barrier of scaling, allowing significant power and performance advantage by utilizing new material science innovations. This technology targets a broad range of embedded segments, including mobile, portable and consumer electronics.

The early parallel development work between ARM and the Common Platform alliance leverages their respective industry-leading expertise in processor IP, physical IP and technology development. This combination will facilitate design scaling and accelerate the market availability of next generation mobile devices with unmatched performance, outstanding battery life and reduced cost.

"Through this early engagement, we are creating the foundation for designing power efficient ARM SoCs for customers of the Common Platform," said Warren East, CEO, ARM . "By utilizing the strength of our advanced microprocessors, our leadership in Physical IP design and advanced technology supported by the Common Platform, customers can accelerate the release of products for electronic devices that service a broad range of consumer applications."

The Common Platform partners expect to continue to expand the eco-system in this collaborative initiative to include more members in the near future. These additional partners will expand the offering of EDA support, services and IP offerings to enable customers to accelerate their time to market on these advanced technologies.

"IBM remains convinced collaborative innovation in an open ecosystem of partners is the key to technology leadership, both now and in the years to come," said Mike Cadigan, general manager, Semiconductor Solutions, IBM. "Today's announcement with ARM extends that strategy to the next level, from IBM research through Common Platform manufacturing to the leading consumer application architecture. With the extensions of our agreements to the 32nm generation, IBM is working together with its alliance partners to deliver leading-edge technology that promises to dramatically change the way we live, work and play."

"Today, customers require a new level of ecosystem interdepency to address the complexity of total system solutions. ARM's collaboration with the Common Platform partners will drive a new level of optimized, power-efficient SoCs," said Chia Song Hwee, president & CEO of Chartered. "The Common Platform's joint development and ecosystem collaboration is the leading model for moving invention to open industry access."

"This collaboration provides our mutual customers with leading design solutions that combine our HKMG breakthroughs in 32nm process technology and ARM's optimized low-power, high-performance cores and libraries," said Dr. Chang Sik Choi, Executive Vice President, Samsung Electronics Co., Ltd. "With high volume manufacturing in our Common Platform fabs, customers will benefit with time to volume advantages critical to success in the fast moving consumer electronics market."

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.